Analysis of pre-treatment tumors reveals gatekeepers of response to CAR T cells dlvr.it/T38KX6 #genetherapy #celltherapy

These guys. Just killing it. Amazing progress in the most needed area!

Twitter fam! We are looking for a research associate to join our awesome team. If you know anyone interested in the interface of protein engineering, structural bio, gene editing and T cell immunotherapy please reach out! Also, please retweet and spread the word!

Check out the new Singh Lab website @ nathansinghlab.com! Huge shout out to the team Maria_llou who was so amazing to work with.

Thanks for sharing our paper on the very low risk of T cell malignancies driven by insertional mutagenesis in a paediatric/young adult CART setting. Impt to contrast with the non-negligible risk of secondary myeloid malignancies seen with CART as with any anti-leukaemic therapy…

Now online in Cancer Discovery: Rational Protein Engineering to Enhance MHC-independent T Cell Receptors - by Ju-Fang Chang, Nathan Singh, and colleagues doi.org/10.1158/2159-8… Test Account

Taken the day Joe Biden announced his candidacy in 2019. A patriot that history will remember for doing the right, hard thing, over and over. We are lucky to have had him as President. Now, let's kick it into gear for Vice President Kamala Harris Kamala HQ and finish this!

NEW - Regulatory Considerations for Genome-Edited T-cell Therapies, on navigating complexities in bringing new technologies to regulatory submissions, clinical trials. From Nathan Singh & colleagues Penn Medicine Cancer Immunology Research #geneediting #CRISPR aacrjournals.org/cancerimmunolr…

Looking for a small meeting with leaders in cell therapy discussing high impact translational research? Look no further! The UChicago Jonas Center Symposium is for you! Please get in touch if you're interested or, better yet, register and join us! cme.uchicago.edu/JCCTS2024

Incredibly creative work highlighting the broad applications of T cell immunotherapy - congrats Jony and team!